Core Insights - The traditional Tibetan medicine industry is experiencing significant growth, with a total output value expected to exceed 3.4 billion yuan by 2024, reflecting a modernization and integration into contemporary healthcare practices [11]. Group 1: Traditional Tibetan Medicine Practices - Tibetan medicinal practices, such as the Tibetan medicinal bath, are gaining popularity for their effectiveness in treating conditions like arthritis, as evidenced by patient testimonials [2][3]. - The Tibetan medicinal bath method is recognized as part of the UNESCO intangible cultural heritage, highlighting its cultural significance and therapeutic benefits [3]. Group 2: Industry Development and Employment - The number of Tibetan medical institutions in Tibet has increased to 64, with over 1.27 million annual treatments provided, indicating a growing acceptance and demand for traditional Tibetan medicine [3]. - The establishment of companies focused on the cultivation and processing of Tibetan medicinal herbs is contributing to job creation, with over 140 jobs generated in the region [7]. Group 3: Modernization and Research - Companies like Tibet Qizheng Tibetan Medicine Co., Ltd. are modernizing the production of Tibetan medicine through standardized manufacturing processes, making products more accessible to contemporary consumers [8]. - Research collaborations with medical and scientific institutions are enhancing the development of new drugs, with over 500 research papers published, indicating a commitment to scientific validation of traditional practices [8]. Group 4: Economic Impact - The sales of specific products, such as pain relief patches, are projected to reach 1.6 billion yuan in 2024, with international sales exceeding 2.8 million yuan last year, showcasing the global market potential for Tibetan medicine [9]. - The Tibetan medicine industry is supported by a robust talent cultivation system, with over 7,000 graduates from Tibetan medicine universities, ensuring a skilled workforce for future growth [11].

与此同时，在社会责任领域，公司同样展现出独特的作为与担当，社会责任实践先后入选"中国民 营企业社会责任优秀案例""企业贡献生物多样性的中国实践""全球契约中国最佳实践案例"。截至2024 年底，奇正藏药连同奇正公司公益基金累计投入1.692亿元用于藏区和西部的医疗、教育、乡村振兴等 社会公益事业。 据悉，全国文明单位是指积极践行社会主义核心价值体系，坚持物质文明建设和精神文明建设两手 抓，各项事业全面协调发展、精神文明建设成效突出，在社会上发挥示范引领作用的单位。 中证报中证网讯（王珞）5月23日，全国精神文明建设表彰大会在北京召开。大会公布第七届全国 文明单位名单，奇正藏药被授予"全国文明单位"称号。 据了解，奇正藏药1995年落户西藏林芝，主营业务为新型藏药的研发、生产和销售，是现代藏药龙 头企业。公司现拥有GMP药厂、GSP营销公司等全资及控股子公司24家，员工3170人，25个独家品种 和141个药品批准文号，产品涵盖骨骼肌肉系统、神经系统、消化系统、心脑血管、呼吸系统、泌尿系 统、妇科、皮肤科、儿科等领域。2024年，公司实现营业收入23.38亿元，同比增长14.32%。 多年来，奇正藏药精准聚焦藏 ...